| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/18/2007 | US20070014801 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 01/18/2007 | US20070014800 Cytokine zalpha11 ligand antibodies |
| 01/18/2007 | US20070014799 Antibody and use of the same |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014797 Method for treating Sjogren's syndrome |
| 01/18/2007 | US20070014796 Method for the production of non-immunogenic proteins |
| 01/18/2007 | US20070014795 Compositions and methods for enhanced dendritic cell maturation and function |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014792 EGFR inhibitors promote axon regeneration |
| 01/18/2007 | US20070014791 Rage-related methods and copositions for treating glomerular injury |
| 01/18/2007 | US20070014790 Transcription control factor zhx3 |
| 01/18/2007 | US20070014789 Humanized antibody conjugates and related methods, assays, reagents, and kits |
| 01/18/2007 | US20070014788 Laminin-5 modulators and uses thereof |
| 01/18/2007 | US20070014787 71 human secreted proteins |
| 01/18/2007 | US20070014786 Methods for treating taxol-induced gut disorder |
| 01/18/2007 | US20070014785 Use of antibodies against CD20 for the treatment of the graft versus host disease |
| 01/18/2007 | US20070014784 Methods and Systems for Treating Injured Cardiac Tissue |
| 01/18/2007 | US20070014775 Inducing an immune mediated destruction of tumor cells by administering to an animal, a mixture of attenuated tumor cells, said cells comprising a plurality of cell surface glycoproteins on which an alpha Gal epitope is present; anticacinogenic agents; tissue-targeted therapy; gene therapy |
| 01/18/2007 | US20070014774 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 01/18/2007 | US20070014735 Buccal delivery system |
| 01/18/2007 | US20070014724 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates |
| 01/18/2007 | US20070014720 Antibodies directed to CD20 and uses thereof |
| 01/18/2007 | US20070014687 Composition and method for deactivating allergenic proteins on surfaces |
| 01/18/2007 | CA2630087A1 Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
| 01/18/2007 | CA2617559A1 Variant iaspp polypeptide and screening assay |
| 01/18/2007 | CA2615028A1 Cross-.beta. structure binding compounds |
| 01/18/2007 | CA2615020A1 Adjuvation through cross-.beta. structure |
| 01/18/2007 | CA2614884A1 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 01/18/2007 | CA2614766A1 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 01/18/2007 | CA2614737A1 Methods for monitoring neuroinflammatory destruction of neurons and for treating diseases having an inflammatory component related to phospholipase a2 |
| 01/18/2007 | CA2614640A1 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 01/18/2007 | CA2614622A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
| 01/18/2007 | CA2614421A1 Sp35 antibodies and uses thereof |
| 01/18/2007 | CA2614321A1 Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
| 01/18/2007 | CA2614320A1 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 01/18/2007 | CA2614314A1 Human anti-madcam antibodies |
| 01/18/2007 | CA2614261A1 Mycoplasma subunit vaccine |
| 01/18/2007 | CA2614183A1 Anti-alpha v beta 6 antibodies and uses thereof |
| 01/18/2007 | CA2613732A1 Thermoreversible immuno-adjuvant emulsion |
| 01/18/2007 | CA2613017A1 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/17/2007 | EP1743947A2 Method for diagnosing non-small cell lung cancers |
| 01/17/2007 | EP1743945A1 Screening method |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743652A1 Vaccine for respiratory and reproductive system infections in cattle |
| 01/17/2007 | EP1743651A1 Vaccine compositions which are obtained from streptomyces |
| 01/17/2007 | EP1743649A1 Treatment and diagnosis of infertility using TGF beta or activin |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743028A2 Polyvalent viral vectors and a system for production thereof |
| 01/17/2007 | EP1743027A1 Mutant pneumolysin proteins |
| 01/17/2007 | EP1742969A2 Methods of identifying neoplasm-specific antibodies and uses thereof |
| 01/17/2007 | EP1742966A2 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 01/17/2007 | EP1742965A2 Treatments for pancreatic cancer |
| 01/17/2007 | EP1742708A2 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 01/17/2007 | EP1742660A2 Treatment of disorders |
| 01/17/2007 | EP1742659A1 Microfluidized oil-in-water emulsions and vaccine compositions |
| 01/17/2007 | EP1742658A2 Cellular permissivity factor for viruses, and uses thereof |
| 01/17/2007 | EP1742657A2 Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| 01/17/2007 | EP1742656A2 Novel peanut skin extract as a vaccine adjuvant |
| 01/17/2007 | EP1742654A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 01/17/2007 | EP1742650A1 Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors |
| 01/17/2007 | EP1742619A2 Pulmonary malarial vaccine |
| 01/17/2007 | EP1504095B1 Site specific listeria integration vectors and methods for using the same |
| 01/17/2007 | EP1432445B1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 01/17/2007 | EP1340088B1 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1185299B1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1086207B1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 01/17/2007 | EP0220273B2 Synthetic antigens for the detection of aids-related disease |
| 01/17/2007 | CN1898390A Promoters for expression in modified vaccinia virus ankara |
| 01/17/2007 | CN1898385A Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 01/17/2007 | CN1898384A Msp-3-like family of genes |
| 01/17/2007 | CN1898268A Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 01/17/2007 | CN1898267A 修饰的抗cd52抗体 Modified anti-cd52 antibody |
| 01/17/2007 | CN1898264A Novel anti-il 13 antibodies for treating cancer |
| 01/17/2007 | CN1897971A Cd40 antibody formulation and methods |
| 01/17/2007 | CN1897970A Specific human antibodies |
| 01/17/2007 | CN1897966A Therapeutic regimens for baff antagonists |
| 01/17/2007 | CN1897920A System and method for transdermal vaccine delivery |
| 01/17/2007 | CN1896229A Production of anti-CD20 intrinsic antibody and its use |
| 01/17/2007 | CN1896094A Angiotensin II receptors I immunogenic peptide section and its use |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895669A Mucosa-immune composite adjuvant |
| 01/17/2007 | CN1895668A Composite mucosa immunoadjuvant for oral vaccine |
| 01/17/2007 | CN1895667A Reovirus inactivated vaccine and its preparation |
| 01/17/2007 | CN1895666A Cow mastitis concatenate inactivated vaccine |
| 01/17/2007 | CN1895295A Biological activating agent with lead adsorbing and removing functions, its preparation and use |
| 01/17/2007 | CN1895066A Anti-body leben tablet (powder) |
| 01/17/2007 | CN1295339C Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
| 01/17/2007 | CN1295325C Virus lysis method |
| 01/17/2007 | CN1294991C Liposome composition for improving intracellular delivery of therapeutic agent |
| 01/16/2007 | US7164008 Water soluble; binds toll-like receptors |
| 01/16/2007 | US7164001 Compositions and methods for the treatment of immune related diseases |
| 01/16/2007 | US7163926 enhancing efficacy of a DNA plasmid vaccine which comprises a naked DNA containing and expressing in vivo a heterologous polynucleotide, an immunogen of equine rhinopheumonia virus, by adding to the DNA plasmid vaccine an adjuvant which is a polymer of acrylic or methacrylic acid |
| 01/16/2007 | US7163818 Especially having a plurality of different K specific hydrolytic tail proteins. |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163798 Method of preparing cow brain homogenate |